GlassScriptPhysician profile
Barry S Rosen
NPI 1851315949
$442,651.72
in general payments reported to CMS, 2019-2025
30 companies · $21K in 2025
The $21K reported for 2025 was more than what 97% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117K · 2020: $52K · 2021: $55K · 2022: $43K · 2023: $99K · 2024: $56K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $135K · Travel and Lodging: $35K · Food and Beverage: $5,501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $135,186.25 |
| Travel and Lodging | $35,138.37 |
| Food and Beverage | $5,500.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirius Medical Systems | $110,058.08 | 2023-2024 | Pintuition |
| Merit Medical Systems INC | $94,496.77 | 2019-2025 | Savi Scout |
| Hologic INC | $74,935.47 | 2019-2025 | Biozorb, Localizer, 3dimensions |
| Icad, INC | $46,625.00 | 2020-2021 | |
| Eton Pharmaceuticals, INC. | $37,625.00 | 2019 | |
| Davol INC. | $26,793.06 | 2021-2025 | Phasix Mesh |
| Intuitive Surgical, INC. | $11,968.72 | 2019 | |
| Focal Therapeutics, INC. | $10,805.08 | 2019-2020 | |
| Endomagnetics LTD | $9,490.62 | 2019-2024 | Magseed, Magtrace |
| Carl Zeiss Meditec, INC. | $8,542.73 | 2019-2021 | |
| Leica Microsystems INC. | $6,083.90 | 2019-2025 | Neoprobe, Mammotome |
| Carl Zeiss Meditec USA, INC. | $1,611.81 | 2021-2022 | |
| Myriad Women'S Health, INC. | $825.00 | 2023 | Myrisk |
| Hologic Sales and Service, LLC | $517.87 | 2022-2025 | Magtrace, Magseed, 3dquorum |
| Bioptics, INC. | $508.68 | 2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qt Imaging, INC. | $300.00 | 2019 | |
| Myriad Genetic Laboratories, INC. | $226.94 | 2021-2024 | Myrisk |
| Stryker Corporation | $169.67 | 2019 | |
| Dilon Technologies, INC. | $159.84 | 2023 | Hemoblast Bellows |
| Axogen | $145.42 | 2025 | |
| Molli Surgical (US) INC | $141.57 | 2024 | |
| Ethicon US, LLC | $140.15 | 2022 | |
| Merck Sharp & Dohme LLC | $130.61 | 2022 | |
| Innocoll Pharmaceuticals Limited | $128.21 | 2022 | |
| Ricoh USA, INC. | $110.00 | 2024 | Ricoh For Healthcare Anatomic Model |
| Astellas Pharma US INC | $38.47 | 2025 | Veozah |
| Novo Nordisk INC | $23.75 | 2022 | |
| Teleflex LLC | $17.06 | 2021 | |
| Medtronic, INC. | $16.37 | 2021 | |
| Lunit Americas, INC. | $15.87 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Rosen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.